Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
- PMID: 23579614
- DOI: 10.1007/s10822-013-9644-8
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
Abstract
Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches. In general, protein crystal structures are prepared prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove atomic clashes, and perform other operations that are not part of the x-ray crystal structure refinement process. In addition, ligands must be prepared to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening. While the prerequisite for proper system preparation is generally accepted in the field, an extensive study of the preparation steps and their effect on virtual screening enrichments has not been performed. In this work, we systematically explore each of the steps involved in preparing a system for virtual screening. We first explore a large number of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys. We then apply a subset of protocols to the DUD database. We show that database enrichment is improved with proper preparation and that neglecting certain steps of the preparation process produces a systematic degradation in enrichments, which can be large for some targets. We provide examples illustrating the structural changes introduced by the preparation that impact database enrichment. While the work presented here was performed with the Protein Preparation Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.
Similar articles
-
Tautomer preference in PDB complexes and its impact on structure-based drug discovery.J Chem Inf Model. 2010 Jun 28;50(6):1062-74. doi: 10.1021/ci900501c. J Chem Inf Model. 2010. PMID: 20515065
-
Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.J Chem Inf Model. 2014 Jan 27;54(1):324-37. doi: 10.1021/ci4005145. Epub 2014 Jan 3. J Chem Inf Model. 2014. PMID: 24358939
-
FINDSITEcomb2.0: A New Approach for Virtual Ligand Screening of Proteins and Virtual Target Screening of Biomolecules.J Chem Inf Model. 2018 Nov 26;58(11):2343-2354. doi: 10.1021/acs.jcim.8b00309. Epub 2018 Oct 16. J Chem Inf Model. 2018. PMID: 30278128 Free PMC article.
-
Use of molecular docking computational tools in drug discovery.Prog Med Chem. 2021;60:273-343. doi: 10.1016/bs.pmch.2021.01.004. Epub 2021 May 27. Prog Med Chem. 2021. PMID: 34147204 Review.
-
A Comprehensive Survey of Prospective Structure-Based Virtual Screening for Early Drug Discovery in the Past Fifteen Years.Int J Mol Sci. 2022 Dec 15;23(24):15961. doi: 10.3390/ijms232415961. Int J Mol Sci. 2022. PMID: 36555602 Free PMC article. Review.
Cited by
-
Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosis.Comput Struct Biotechnol J. 2021 Apr 19;19:2423-2446. doi: 10.1016/j.csbj.2021.04.034. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34025934 Free PMC article.
-
Discovery of Flavonoids as Novel Inhibitors of ATP Citrate Lyase: Structure-Activity Relationship and Inhibition Profiles.Int J Mol Sci. 2022 Sep 15;23(18):10747. doi: 10.3390/ijms231810747. Int J Mol Sci. 2022. PMID: 36142671 Free PMC article.
-
Metadynamics-Based Approaches for Modeling the Hypoxia-Inducible Factor 2α Ligand Binding Process.J Chem Theory Comput. 2021 Jul 13;17(7):3841-3851. doi: 10.1021/acs.jctc.1c00114. Epub 2021 Jun 3. J Chem Theory Comput. 2021. PMID: 34082524 Free PMC article.
-
Repurposing N-hydroxy thienopyrimidine-2,4-diones (HtPD) as inhibitors of human cytomegalovirus pUL89 endonuclease: Synthesis and biological characterization.Bioorg Chem. 2022 Dec;129:106198. doi: 10.1016/j.bioorg.2022.106198. Epub 2022 Oct 12. Bioorg Chem. 2022. PMID: 36265353 Free PMC article.
-
Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening.Front Pharmacol. 2020 Jun 17;11:905. doi: 10.3389/fphar.2020.00905. eCollection 2020. Front Pharmacol. 2020. PMID: 32625097 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
